{
"@context": "https://schema.org",
"@type": "Article",
"headline": "EU Digital Omnibus: What the Proposed Reforms Mean for Pharma and MedTech",
"url": "https://www.lexblog.com/2026/02/26/eu-digital-omnibus-what-the-proposed-reforms-mean-for-pharma-and-medtech/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-KMGGK8RG",
"url": "https://www.lexblog.com/lib/KMGGK8RG/"
},
"datePublished": "2026-02-26T10:49:25-05:00",
"dateModified": "2026-02-26T10:49:50-05:00",
"author": {
"@type": "Person",
"name": "Alexander Roussanov, Fabien Roy, Camille Vermosen"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Arnold & Porter Kaye Scholer LLP"
},
"organizationScope": "at-publication",
"isPartOf": "BioSlice Blog",
"about": "Privacy and Cybersecurity ยท Technology and AI",
"sourceUrl": "https://www.biosliceblog.com/?p=3959",
"sourceStability": "may-move"
}